Meetings

BPNS SFNP Joint Meeting 2022
Start Date
End Date
Thursday 1 Dec 2022 14:00 PM
Friday 2 Dec 2022 17:15 PM
Location
One Birdcage Walk, London, SW1H 9JJ
Details

We hope you will be able to join us at the upcoming BPNS meeting which we are hosting in conjunction with our French colleagues (SFNP).  This international meeting will include lectures from renowned clinical academic and experienced clinicians in the peripheral nerve field from across the UK and France; it will be held in English.  This will be an exclusively in-person meeting hosted at the Institute of Mechanical Engineers in the heart of Westminster in central London, which overlooks St James's Park and was built in 1899.  The beautiful Georgian period decor is supplemented by engineering memorabilia.  Don't forget to login to our website before booking if you are a member. 

This longer meeting than usual, over a day and a half, will have more invited speakers that we usually do, but will still have some traditional case presentations.  Please submit clinical cases and research work as poster presentations, and we shall select some to be given as oral presentations.  These should both be submitted through the website in the normal way (this page: https://www.bpns.org.uk/abstract-submit.aspx); we hope we can include all submitted presentations.  There will be prizes for the best posters and oral presentations given by trainees.  A subsidised dinner at the Churchill War Rooms will take place on the Thursday evening and can be booked (as a separate event) via our website.

Location and travel information

Directions and venue location information are available here: https://www.onebirdcagewalk.com/docs/default-source/new-website/directions.pdf?sfvrsn=8.  Victoria, Waterloo and Charing Cross mainline stations are approximately a 15-20 minute walk from the venue.  If travelling by car, Q-Park Westminster is a safe and secure car park conveniently located just ten minutes away; a 10% discount code can be obtained by contacting HonSec@bpns.org.uk in advance of the meeting.

Accommodation

We have secured some discounted rooms at the Strand Palace Hotel: Strand Palace, 372 Strand, London WC2R 0JJ.  If any BPNS members wish to make bookings they must send their requests to groups@strandpalacehotel.co.uk quoting 'BPNS' to unlock cheaper rates.  They will offer Super Singles at £195p/n, Cozy Doubles for Sole Use at £235 p/n, or Standard Doubles (double occupancy) £250 p/n; breakfast and VAT inclusive.  They will then make the booking and contact you for your credit card details.

Payment information

Cost for members and non-members alike is £100 for the meeting, or £75 for associate members and French trainees (who do not have to become members, but should contact SFNP honorary secretary Dr Marion Masingue, who will advise our treasurer of their trainee status).  Due to PayPal changes, our usual payment system through the website doesn't work, so instead register through the website 'for free' and then pay separately through PayPal, either by searching for Aisling.Carr@nhs.net through PayPal or more simply by typing PayPal.me/bpns22 into your web browser: you will then be asked to log in or sign up to PayPal before being asked to set the amount to pay Aisling Carr, our treasurer.  If you do not have a PayPal account and do not wish to sign up, you can email aisling.carr@nhs.net and bring a checkbook when you attend the meeting.

Abstracts (can change before the event)
TitleLead AuthorStatus 
Previous and Subsequent Diagnosis in CIDP & Heredofamilial Amyloidosis with Regional Variations in England: HES AnalysisMonja Stein Finished Version View
Plasma neurofilament light chain as a reliable biomarker of hereditary ATTR amyloidosis - A Swiss reference center experienceValentin Loser Finished Version View
Novel Homozygous COA8 Variant Leads to Cytochrome c Oxidase Deficiency Mimicking a Chronic Inflammatory Demyelinating PolyradiculoneuropathySean Freeman Finished Version View
Creation of a preliminary POEMS-specific RODS using the UK POEMS cohortRyan YS Keh Finished Version View
Anti-AGO1 antibodies identify a subgroup of sensory neuronopathy responding better to immunomodulatory treatment Christian P. Moritz Finished Version View
The antibody repertoire of inflammatory sensory neuronopathies targets pathways of the innate and adaptative immune system. Christian P. Moritz Finished Version View
Phenotype and molecular diagnostic yield in SMN1-negative Spinal Muscular AtrophyGorka Fernández-Eulate Finished Version View
Not just a ‘bag-of-worms’: Subclinical electrodiagnostic markers as a useful tool in the identification, and monitoring, of Peripheral Nerve Hyperexcitability. Nonnie McNicholas Finished Version View
A relatively common cause of hereditary motor neuropathy due to a founder mutation in VWA1 Sara Nagy Finished Version View
Response to intravenous immunoglobulin in anti-FGFR3 positive sensory neuronopathyAkin Nihat Finished Version View
Monitoring of dysautonomia in Guillain-Barré syndrome: A multicentre retrospective cohort study  Syed Shehroz Ul Huda Finished Version View
A fascinating caseNiall Doherty Finished Version View
Demyelinating neuropathy with sub-acute, upper limb onsetChristopher J Record Finished Version View
High prevalence of large fibre neuropathy following recreational nitrous oxide use: the Queen’s Hospital, BHRUT experienceAkin Nihat Finished Version View
Rasch analysis of the Fatigue Severity Scale (FSS) and the Unidimensional Self-Efficacy (USE) Scale in Neuromuscular Disorders and comparison between sex, age and diagnosesJosh Fulton Finished Version View
Anti-MAG IgG antibodies occur and matter in anti-MAG neuropathyEmilien Delmont Finished Version View
Neurogenic involvement in COL6 mutated patientsNur Villar-Quiles Finished Version View
Updates on RFC1 disease: novel insights into the phenotypic and genotypic spectrumRiccardo Curro Finished Version View
Mycophenolate maintenance in CIDP facilitates reduction in IVIg dose and improvement in outcome measuresAmar Elsaddig Finished Version View
Contribution of nerve biopsy in the diagnosis of peripheral neuropathies associated with lymphoid hemopathies: a retrospective analysis of 97 cases.Louise Bicart-Sée Finished Version View
Neurological and cardiac assessment of 130 TTR gene mutation carriers: a retrospective monocentric studyDiane Beauvais Finished Version View
Immune mediated peripheral neuropathies: first results of the real-life data collection platform NEUROQUALIJean-Philippe Plançon Finished Version View
Guillain-Barré syndrome in patients with CMT1a: an unpredictable course Loïc Sellier Montaigne Finished Version View
Programme
TimeType Presenter
13:55Registration Arrive and registration  
14:20Lecture Welcome Professor Michael Lunn
14:30Lecture Amyloid Mechanisms Professor Julian Gillmore
15:05Lecture Amyloid Treatments Professor Andoni Echaniz-Laguna
15:40Refreshment Break and coffee  
16:10Lecture Update on novel antibodies in diagnosis Dr Jerome Devaux
16:25Lecture Research and development of novel biomarkers or diagnostics Dr Jean-Christophe Antoine
16:40Lecture A life in inflammatory neuropathies Professor Hugh Willison, Glasgow
17:20Close  
08:30Registration Arrive and registration  
09:00Lecture Demyelination and conduction block - use and misuse? Dr Arjuna Nagendran
09:15Lecture Optimal practical use of imaging in peripheral neuropathy diagnostics Dr Christophe Vandendries
09:30Lecture Developments in peripheral nerve imaging on the diagnostic horizon Professor Marie Faruch
09:45Lecture Advancing utility of CSF analysis Professor Michael Lunn
10:00Lecture Perineuroma cases and genetics Dr Chris Record
10:15Lecture How to use nerve biopsies in the 21st Century Dr Laurent Magy
10:30Refreshment Break and coffee  
11:00Lecture Checkpoint inhibitors - complications and management Dr Aisling Carr
11:20Lecture Nitrous oxide - An epidemic? Dr Emilien Delmont
11:40Lecture Advances in the understanding and treatment of nutritional neuropathies Dr Alex Rossor
12:00Other Junior QUIZ - Dr James Stevens/Dr Hadi Manji  
12:30Refreshment Lunch and Posters  
13:30Lecture New Genes/use of WGS Professor Mary Reilly
13:45Lecture Muscle MRI as an outcome measure AND Emerging role of MRI neurography in CMT Dr Jasper Morrow and Dr Shahram Attarian
14:15Lecture Emerging genetic therapies (not amyloid) Dr Tanya Stojkovic
14:30Abstract Updates on RFC1 disease: novel insights into the phenotypic and genotypic spectrum MD Riccardo Curro
14:45Abstract A relatively common cause of hereditary motor neuropathy due to a founder mutation in VWA1 MD Msc Sara Nagy
15:00Refreshment Break and coffee  
15:30Abstract Anti-AGO1 antibodies identify a subgroup of sensory neuronopathy responding better to immunomodulatory treatment Dr Christian P Moritz
15:45Abstract Contribution of nerve biopsy in the diagnosis of peripheral neuropathies associated with lymphoid hemopathies: a retrospective analysis of 97 cases. Dr Louise Bicart-Sée
16:00Abstract Monitoring of dysautonomia in Guillain-Barré syndrome: A multicentre retrospective cohort study   Dr Syed Shehroz Ul Huda
16:15Abstract Neurological and cardiac assessment of 130 TTR gene mutation carriers: a retrospective monocentric study Dr Diane Beauvais
16:30Lecture Clinicopathological conference (CPC) Dr Yann Pereon
17:15Close Final words from Professor Michael Lunn  

Latest News

Queen Square Annual Update in Neuromuscular Disorders

 This course will be held from Tuesday 7th to Thursday 9th May in the Clinical Neuroscience Lecture Theatre, Lower ground, 33 Queen Square, London WC1N 3B

 REGISTRATION  (right click and select - open in new window or open in new tab)     

 PROGRAMME

Brain Fellowships

Applications are invited for 1 year fellowships funded by the Guarantors of Brain. These fellowships provide bridging salary support  to early career clinicians based in the UK prior to obtaining a research fellowship. Further details can be found HERE

Hereditary Neuropathy Serine Trial

The Hereditary Sensory Neuropathy Serine trial (SENSE trial)  ClinicalTrials.gov Identifier:        NCT06113055

The Hereditary Sensory Neuropathy Serine trial (SENSE trial) is open to recruitment.  This is a randomised double-blind placebo-controlled trial of L-serine in Hereditary Sensory Neuropathy type 1 (HSN1) due to variants in SPTLC1/2 gene.

 This is a single-centre study being conducted at the National Hospital for Neurology and Neurosurgery, London UK. The Chief Investigator for this trial is Professor Mary M Reilly.  If you have any affected patients who you think may interested in taking part then please invite them to contact the trial team for further information.

Recruitment will close August 2024.

New UK Charity for Peripheral Neuropathy

The BPNS wish to facilitate setup of a new charity for peripheral neuropathy in the UK.  There is no charity or association in the UK which supports people with all the many causes of peripheral neuropathy.  Only a few specific causes of neuropathy have a UK charity, such as CMT-UK, GAIN and Diabetes UK.  There is no UK charity to support idiopathic neuropathy, painful small fibre neuropathy (except general pain charities), brachial neuritis, carpal tunnel and entrapment neuropathies, chemotherapy neuropathy (except cancer charities), etc. Several people have come forward to assist with this and work is progressing to get the new charity up and running.

More news »